ARTICLE | Company News
Progenics other research news
March 6, 2000 8:00 AM UTC
PGNX said that it identified synthetic sulfated peptides derived from the HIV co-receptor CCR5 that blocked the binding of HIV to cell surface CCR5 and inhibited HIV strains from entering target cells...